{"organizations": [], "uuid": "8358e9d8e31f17cf8749eec3a40feacd15234e3c", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-shenzhen-hepalink-pharmaceutical-p/brief-shenzhen-hepalink-pharmaceutical-plans-jv-with-u-s-firm-aridis-pharmaceuticals-idUSL4N1Q10D7", "country": "US", "domain_rank": 408, "title": "BRIEF-Shenzhen Hepalink Pharmaceutical Plans JV With U.S. firm Aridis Pharmaceuticals", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-11T15:48:00.000+02:00", "replies_count": 0, "uuid": "8358e9d8e31f17cf8749eec3a40feacd15234e3c"}, "author": "", "url": "https://www.reuters.com/article/brief-shenzhen-hepalink-pharmaceutical-p/brief-shenzhen-hepalink-pharmaceutical-plans-jv-with-u-s-firm-aridis-pharmaceuticals-idUSL4N1Q10D7", "ord_in_thread": 0, "title": "BRIEF-Shenzhen Hepalink Pharmaceutical Plans JV With U.S. firm Aridis Pharmaceuticals", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}, {"name": "california", "sentiment": "none"}, {"name": "hong kong", "sentiment": "none"}], "organizations": [{"name": "aridis pharmaceuticals", "sentiment": "negative"}, {"name": "reuters) - shenzhen hepalink pharmaceutical co ltd", "sentiment": "none"}, {"name": "aridis pharmaceuticals reuters staff", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 11 (Reuters) - Shenzhen Hepalink Pharmaceutical Co Ltd :\n* SAYS IT PLANS TO SET UP JV WITH CALIFORNIA'S ARIDIS PHARMACEUTICALS INC Source text in Chinese: bit.ly/2EWE579 Further company coverage: (Reporting by Hong Kong newsroom)\n ", "external_links": [], "published": "2018-02-11T15:48:00.000+02:00", "crawled": "2018-02-11T15:59:53.006+02:00", "highlightTitle": ""}